Zenith Drugs Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 16, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	737	1,230	1,075	-	-	-
Market Cap Growth	-24.43%	14.35%	-	-	-	-
Enterprise Value	1,251	1,389	1,332	-	-	-
Last Close Price	43.00	71.70	62.48	-	-	-
PE Ratio	19.55	17.17	11.27	-	-	-
PS Ratio	0.51	0.92	0.82	-	-	-
PB Ratio	1.03	1.77	1.73	-	-	-
P/TBV Ratio	1.07	1.78	1.73	-	-	-
EV/Sales Ratio	0.87	1.04	1.01	-	-	-
EV/EBITDA Ratio	9.20	9.79	7.38	-	-	-
EV/EBIT Ratio	15.09	12.38	7.96	-	-	-
Debt / Equity Ratio	0.72	0.70	0.39	1.47	1.55	1.73
Debt / EBITDA Ratio	3.81	3.43	1.33	2.64	2.75	2.20
Net Debt / Equity Ratio	0.72	0.70	0.24	1.46	1.31	1.52
Net Debt / EBITDA Ratio	3.78	3.41	0.84	2.61	2.31	1.94
Net Debt / FCF Ratio	-	-1.28	-0.72	-2.50	-177.62	-20.30
Asset Turnover	-	0.90	1.13	1.38	1.59	1.63
Inventory Turnover	-	2.68	3.47	4.38	7.67	9.34
Quick Ratio	0.75	0.77	1.19	0.69	0.75	0.84
Current Ratio	1.44	1.45	1.76	1.17	1.15	1.20
Return on Equity (ROE)	-	10.88%	23.86%	32.71%	29.71%	39.03%
Return on Assets (ROA)	-	4.74%	9.01%	6.46%	5.98%	8.05%
Return on Invested Capital (ROIC)	4.33%	8.89%	19.85%	17.64%	15.48%	19.39%
Return on Capital Employed (ROCE)	9.80%	13.60%	23.90%	32.70%	25.00%	35.10%
Earnings Yield	5.12%	5.82%	8.87%	-	-	-
FCF Yield	-	-30.56%	-19.69%	-	-	-
Dividend Yield	-	-	0.80%	-	-	-
Buyback Yield / Dilution	70.12%	-	-42.91%	-	-	-
Total Shareholder Return	70.12%	-	-42.11%	-	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.